Athira Pharma, Inc. (ATHA) Misses Q1 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• Google and Blackstone data-center venture hits delays at key sites - Bloomberg
• Goldgroup Mining launches $75M private placement with $60M committed